Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: New Zealand Society for the Study of Diabetes, (Grant/Award Number: ‘NZSSD award 2015’).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
1. Uchida K, Okuda S, Tanaka K. Method of inhibiting glycolysis in blood samples. US Patent 4,780,419. 1988 Oct 4. 20. Available at: https://www.google.com/patents/US4780419. Accessed: 5 Sep 2017.Search in Google Scholar
2. Saracevic A, Dukic L, Juricic G, Milevoj Kopcinovic L, Mirosevic G, Simundic AM. Various glycolysis inhibitor-containing tubes for glucose measurement cannot be used interchangeably due to clinically unacceptable biases between them. Clin Chem Lab Med 2018;56:236–41.10.1515/cclm-2017-0279Search in Google Scholar
3. Venosafe glycaemia tube with unique FC-mixture. Available at: http://www.elitmedical.com/images/Terumo/venosafe_glycaemia_en.pdf. Accessed: 5 Sep 2017.Search in Google Scholar
5. Gros M, Vrhovec S, Brumen M, Svetina S, Zeks B. Low pH induced shape changes and vesiculation of human erythrocytes. Gen Physiol Biophys 1996;15:145–63.Search in Google Scholar
7. Rudenko SV. Erythrocyte morphological states, phases, transitions and trajectories. Biochimica et Biophysica Acta (BBA) – Biomembranes 2010;1798:1767–78.10.1016/j.bbamem.2010.05.010Search in Google Scholar PubMed
8. Carey R, Lunt H, Heenan HF, Frampton CM, Florkowski CM. Collection tubes containing citrate stabiliser over-estimate plasma glucose, when compared to other samples undergoing immediate plasma separation. Clin Biochem 2016;18: 1406–11.10.1016/j.clinbiochem.2016.05.017Search in Google Scholar PubMed
©2018 Walter de Gruyter GmbH, Berlin/Boston